Wuhan University Journal of Natural Sciences

, Volume 24, Issue 1, pp 45–56 | Cite as

Mechanism Research of Reducing Obesity-Induced Insulin Resistance in the White Adipose Tissue by Knockdown of Neuropeptide Y Expression in the Dorsomedial Hypothalamus

  • Qiuran Zhai
  • Qian Qin
  • Peng Chen
  • Zhihui Cui
  • Jiao Wang
  • Jianxiang Zhang
  • Shoujun WangEmail author


This study investigated the specific mechanism of knockdown of neuropeptide Y (NPY) in reducing obesity-induced insulin resistance in the white adipose tissue. Adeno-associated virus (AAV)-mediated RNAi was utilized to downregulate NPY expression in rats fed either regular chow or high fat diet. By investigating the differences in rat body weight and food intake, we assessed the effect of knockdown of NPY expression on insulin sensitivity and β-cell proliferation. Glucose consumption and 2-[3H]DG uptake in 3T3-L1 adipocytes were assessed to determine the molecular mechanisms. The results showed that knockdown of NPY expression in the dorsomedial hypothalamus (DMH) reduced obesityinduced insulin resistance, increased glucose consumption, and decreased 2-[3H]DG uptake in 3T3-L1 adipocytes via the PI3K/Akt/GSK-3β signaling pathways and the NPY Y5 receptor.

Key words

knockdown of neuropeptide Y(NPY) insulin resistance glucose consumption glucose intake PI3K/Akt/GSK-3β signaling pathways 

CLC number

Q 591 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Jeon Y K, Lee J G, Kim S S, et al. Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women [J]. Endocr J, 2011, 58(2): 87–93.CrossRefGoogle Scholar
  2. [2]
    Pirgon O, Bilgin H, Tolu I, et al. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease [J]. Clin Endocrinol (Oxf), 2011, 75(2): 189–195.CrossRefGoogle Scholar
  3. [3]
    Bruce K D, Hanson M A. The developmental origins, mechanisms, and implications of metabolic syndrome [J]. J Nutr, 2010, 140(3): 648–652.CrossRefGoogle Scholar
  4. [4]
    Kim Y J, Bi S. Knockdown of neuropeptide Y in the dorsomedial hypothalamus reverses high-fat diet-induced obesity and impaired glucose tolerance in rats [J]. Am J Physiol Regul Integr Comp Physiol, 2016, 310(2): R134–R142.CrossRefGoogle Scholar
  5. [5]
    Long M, Zhou J, Li D, et al. Long-Term Over-Expression of Neuropeptide Y in hypothalamic paraventricular nucleus contributes to adipose tissue insulin resistance partly via the Y5 receptor [J]. PLoS One, 2015, 10(5): e0126714.CrossRefGoogle Scholar
  6. [6]
    Wang Q, Bing C, Al-Barazanji K, et al. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat [J]. Diabetes, 1997, 46(3): 335–341.CrossRefGoogle Scholar
  7. [7]
    Yang L, Scott K A, Hyun J, et al. Role of dorsomedial hypothalamic neuropeptide Y in modulating food intake and energy balance[J]. J Neurosci, 2009, 29(1): 179–190.CrossRefGoogle Scholar
  8. [8]
    Wortley K E, Anderson K D, Yasenchak J, et al. Agoutirelated protein-deficient mice display an age-related lean phenotype [J]. Cell Metab, 2005, 2(6): 421–427.CrossRefGoogle Scholar
  9. [9]
    Coll A P, Farooqi I S, O’Rahilly S. The hormonal control of food intake [J]. Cell, 2007, 129(2): 251–262.CrossRefGoogle Scholar
  10. [10]
    Elmquist J K, Maratos-Flier E, Saper C B, et al. Unraveling the central nervous system pathways underlying responses to leptin [J]. Nat Neurosci, 1998, 1(6): 445–450.CrossRefGoogle Scholar
  11. [11]
    Kesterson R A, Huszar D, Lynch C A, et al. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome [J]. Mol Endocrinol, 1997, 11(5): 630–637.CrossRefGoogle Scholar
  12. [12]
    Bi S, Ladenheim E E, Schwartz G J, et al. A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats [J]. Am J Physiol Regul Integr Comp Physiol, 2001, 281(1): R254–R260.CrossRefGoogle Scholar
  13. [13]
    Beck B. Neuropeptide Y in normal eating and in genetic and dietary-induced obesity [J]. Philos Trans R Soc Lond B Biol Sci, 2006, 361(1471): 1159–1185.CrossRefGoogle Scholar
  14. [14]
    Chao P T, Yang L, Aja S, et al. Knockdown of NPY expression in the dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced obesity [J]. Cell Metab, 2011, 13(5): 573–583.CrossRefGoogle Scholar
  15. [15]
    Lin S, Boey D, Herzog H. NPY and Y receptors: Lessons from transgenic and knockout models [J]. Neuropeptides, 2004, 38(4): 189–200.CrossRefGoogle Scholar
  16. [16]
    Kanatani A, Mashiko S, Murai N, et al. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: Comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice [J]. Endocrinology, 2000, 141(3): 1011–1016.CrossRefGoogle Scholar
  17. [17]
    Gerald C, Walker M W, Criscione L, et al. A receptor subtype involved in neuropeptide-Y-induced food intake[J]. Nature, 1996, 382(6587): 168–171.CrossRefGoogle Scholar
  18. [18]
    Pedragosa-Badia X, Stichel J, Beck-Sickinger A G. Neuropeptide Y receptors: How to get subtype selectivity [J]. Front Endocrinol (Lausanne), 2013, 4: 5.CrossRefGoogle Scholar
  19. [19]
    Criscione L, Rigollier P, Batzl-Hartmann C, et al. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor [J]. J Clin Invest, 1998, 102(12): 2136–2145.CrossRefGoogle Scholar
  20. [20]
    Elghazi L, Balcazar N, Bernal-Mizrachi E. Emerging role of protein kinase B/Akt signaling in pancreatic beta-cell mass and function [J]. Int J Biochem Cell Biol, 2006, 38(2): 157–163.Google Scholar
  21. [21]
    Leng S, Zhang W, Zheng Y, et al. Glycogen synthase kinase 3 beta mediates high glucose-induced ubiquitination and proteasome degradation of insulin receptor substrate 1 [J]. J Endocrinol, 2010, 206(2): 171–181.CrossRefGoogle Scholar
  22. [22]
    Liu Y, Tanabe K, Baronnier D, et al. Conditional ablation of Gsk-3? in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice [J]. Diabetologia, 2010, 53(12): 2600–2610.CrossRefGoogle Scholar
  23. [23]
    Paxinos G. The Mouse Brain in Stereotaxic Coordinates [M]. Pittsburgh: Academic Press, 2001.Google Scholar
  24. [24]
    Guan X M, Yu H, Trumbauer M, et al. Induction of neuropeptide Y expression in dorsomedial hypothalamus of diet-induced obese mice [J]. Neuroreport, 1998, 9(15): 3415–3419.CrossRefGoogle Scholar
  25. [25]
    Bi S, Kim Y J, Zheng F. Dorsomedial hypothalamic NPY and energy balance control [J]. Neuropeptides, 2012, 46(6): 309–314.CrossRefGoogle Scholar
  26. [26]
    Imai Y, Patel H R, Hawkins E J, et al. Insulin secretion is increased in pancreatic islets of neuropeptide Y-deficient mice [J]. Endocrinology, 2007, 148(12): 5716–5723.CrossRefGoogle Scholar
  27. [27]
    Cho Y R, Kim C W. Neuropeptide Y promotes β-cell replication via extracellular signal-regulated kinase activation [J]. Biochem Biophys Res Commun, 2004, 314(3): 773–780.CrossRefGoogle Scholar
  28. [28]
    Cho H, Mu J, Kim J K, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB β) [J]. Science, 2001, 292(5522): 1728–1731.CrossRefGoogle Scholar
  29. [29]
    Tanabe K, Liu Z, Patel S, et al. Genetic deficiency of glycogen synthase kinase-3β corrects diabetes in mouse models of insulin resistance [J]. PLoS Biol, 2008, 6(2): e37.CrossRefGoogle Scholar
  30. [30]
    Mussmann R, Geese M, Harder F, et al. Inhibition of GSK3 promotes replication and survival of pancreatic beta cells [J]. J Biol Chem, 2007, 282(16): 12030–12037.CrossRefGoogle Scholar
  31. [31]
    Tang-Christensen M, Kristensen P, Stidsen C E, et al. Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y [J]. J Endocrinol, 1998, 159(2): 307–312.CrossRefGoogle Scholar
  32. [32]
    Ishihara A, Kanatani A, Mashiko S, et al. A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice [J]. Proc Natl Acad Sci USA, 2006, 103(18): 7154–7158.CrossRefGoogle Scholar
  33. [33]
    Rosmaninho-Salgado J, Cortez V, Estrada M, et al. Intracellular mechanisms coupled to NPY Y2 and Y5 receptor activation and lipid accumulation in murine adipocytes [J]. Neuropeptides, 2012, 46(6): 359–366.CrossRefGoogle Scholar

Copyright information

© Wuhan University and Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Qiuran Zhai
    • 1
  • Qian Qin
    • 2
  • Peng Chen
    • 1
  • Zhihui Cui
    • 3
  • Jiao Wang
    • 1
  • Jianxiang Zhang
    • 1
  • Shoujun Wang
    • 1
    Email author
  1. 1.Endocrinology DepartmentThe First Affiliated Hospital of Zhengzhou UniversityHenanChina
  2. 2.Physical Examination CenterThe First Affiliated Hospital of Zhengzhou UniversityHenanChina
  3. 3.Endocrinology DepartmentZhengzhou Central HospitalHenanChina

Personalised recommendations